Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin

Salic, Kanita, Morrison, Martine C., Verschuren, Lars, Wielinga, Peter Y., Wu, Lijun, Kleemann, Robert, Gjorstrup, Per, Kooistra, Teake·2016·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2016.05.001

Cited by (105)

Items 101–105 of 105

  1. Encapsulation of Marine Compounds in Lipid Nanoparticles for Healthcare Products
    Rita Favas, Andreia F. Peixoto, Hugo Almeida, Ana Catarina Silva · 2026 · Springer handbooks
  2. Metabolic-epigenetic axis in cardiovascular inflammatory injury: regulatory mechanisms and intervention strategies
    Xiaoyu Yu, Cong Cui, Jiyong He, Xiaoyu Guan, Zhe Zhang · 2026 · Frontiers in Cardiovascular Medicine
  3. The Role of Immunoresolvents in Atherosclerosis: A Mini‐Review on Their Biology and Therapeutic Opportunities
    Ramin Lotfi, Alireza Nasirifar, Hoda Rahmani, Sara Falahi, Meysam Kashiri · 2026 · Health Science Reports
  4. Fatty acid metabolites concentration in the early phase of myocardial infarction and its relation to left ventricular ejection fraction
    Szymon Olędzki, Arnold Kukowka, Aldona Siennicka, Radosław Kiedrowicz, Małgorzata Zielska, Ewa Stachowska, Dominika Maciejewska · 2026 · Prostaglandins & Other Lipid Mediators
  5. Resolution Medicine: Steps to Uncovering the Specialized Pro-resolving Mediator Superfamily and Their Potent Functions in Resolving Inflammation
    Charles Nicholas Serhan · 2026 · Current topics in microbiology and immunology